Contact
Please use this form to send email to PR contact of this press release:
Stock Dividend & Share Structure Reduction to Counter Short Selling and Boost Institutional Investment: NASDAQ: NRXP
TO:
Matthew Duffy, Chief Business Officer
NRx Pharmaceuticals, Inc.
+1 484-254-6134